[Clinical study on fludarabine combined with cytarabine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia].

Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology

Volumn 17, Issue 3, 2009, Pages 774-776

  Yao, Yi Yun ^a   Zhu, Q ^b   Zou, Li Fang ^b   Dou, Hong Ju ^b   Chen, Yi Min ^b   Tang, Yong ^b   Hu, Jun Pei ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DRUG DERIVATIVE; FLUDARABINE; VIDARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; RECURRENT DISEASE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; RECURRENCE; VIDARABINE;

EID: 79955777056     PISSN: 10092137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)